Jove
Visualize
Contact Us

Related Experiment Videos

Designing better phages.

S S Skiena1

  • 1Applied Algorithm Laboratory, Dept. of Computer Science, State University of New York, Stony Brook, NY 11794-4400, USA. skiena@cs.sunysb.edu

Bioinformatics (Oxford, England)
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dealing with errors in interactive sequencing by hybridization.

Bioinformatics (Oxford, England)·2001
Same author

A case study in genome-level fragment assembly.

Bioinformatics (Oxford, England)·2000
Same author

Positional sequencing by hybridization.

Computer applications in the biosciences : CABIOS·1996
Same author

Reconstructing strings from substrings.

Journal of computational biology : a journal of computational molecular cell biology·1995
Same author

A partial digest approach to restriction site mapping.

Bulletin of mathematical biology·1994
Same author

A partial digest approach to restriction site mapping.

Proceedings. International Conference on Intelligent Systems for Molecular Biology·1993
Same journal

Biomedical Concept Recognition with Error-aware Negative-enhanced Ranking Framework.

Bioinformatics (Oxford, England)·2026
Same journal

TEDLH: Domain HMMs for sensitive detection of remote homologues.

Bioinformatics (Oxford, England)·2026
Same journal

PLNFGL: Joint Estimation of Multi-Condition Gene Networks from Single-cell RNA-seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

MCFST: Spatial domain identification method based on multi-view graph convolutional network and graph fusion network.

Bioinformatics (Oxford, England)·2026
Same journal

SpaBiT: Enhancing Spatial Transcriptomics Resolution via Bidirectional Attention Transformers.

Bioinformatics (Oxford, England)·2026
Same journal

EDEL: Enhancing Dense Retrievers for Curation of Biomedical Knowledge Bases.

Bioinformatics (Oxford, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

We engineered bacteriophage genomes to enhance their antibacterial properties by redesigning their genetic code. This method protects phages from restriction enzymes without altering their protein functions, improving their use as therapeutic agents.

Area of Science:

  • Synthetic Biology
  • Genomics
  • Antimicrobial Research

Background:

  • Bacteriophages (phages) are viruses that infect bacteria and show promise as antibacterial agents.
  • Phage therapy is limited by bacterial defense mechanisms, such as restriction-modification systems, that degrade foreign DNA.
  • Existing phage genomes contain sequences recognized by these restriction enzymes, hindering their efficacy.

Purpose of the Study:

  • To develop a genome engineering method to protect bacteriophages from restriction enzymes.
  • To maintain wild-type phage protein function while minimizing the presence of restriction sites.
  • To explore the evolutionary reasons for the persistence of restriction sites in phage genomes.

Main Methods:

  • Exploited the degeneracy of the genetic code (triplet redundancy) to recode phage genomes.

Related Experiment Videos

  • Developed an efficient algorithm to minimize restriction sites against defined sets of restriction enzymes.
  • Validated the method by demonstrating functional phage genomes with significantly reduced susceptibility to enzyme degradation.

    • Main Results:

    • Successfully designed engineered phage genomes that avoid a large number of restriction sites.
    • Demonstrated that these genomic modifications do not alter the proteins produced by the phages.
    • Showed significant protection of engineered phage genomes against broad sets of restriction enzymes without functional loss.

    Conclusions:

    • Genome-level engineering is a viable strategy to enhance bacteriophage efficacy as antibacterial agents.
    • Exploiting triplet code redundancy offers a powerful tool for creating robust phage therapies.
    • The study provides insights into evolutionary pressures and motivates further research in synthetic phage genomics.